Bowel-cleansing drugs to get black-box warning in U.S.

12/11/2008 | Washington Post (tiered subscription model), The

The FDA ordered a black-box warning for Salix Pharmaceuticals' Visicol and OsmoPrep to alert consumers about the risk of kidney injury from the oral sodium phosphate drugs. The warning is intended for patients older than 55, people who are dehydrated or have kidney disorders and individuals who use medicines that affect kidney function.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Actuary
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI